Dupilumab reduces exacerbations and improves lung function in uncontrolled, moderate-to-severe asthma patients across prior historical exacerbation subgroups in the phase 3 LIBERTY ASTHMA QUEST study

被引：0
|
作者：
Ford, L. [1 ]
Corren, J. [2 ]
Kuna, P. [3 ]
Dong, Q. [4 ]
Staudinger, H. [5 ]
Maroni, J. [6 ]
Rowe, P. [5 ]
Amin, N. [6 ]
Pirozzi, G. [5 ]
Ruddy, M. [6 ]
Akinlade, B. [6 ]
Graham, N. M. H. [6 ]
Teper, A. [5 ]
机构：
[1] Ctr Asthma & Allergy, Bellevue, WA USA
[2] Ronald Reagan UCLA Med Ctr, Santa Monica, CA USA
[3] Med Univ Lodz, Lodz, Poland
[4] Sanofi Genzyme, Cambridge, England
[5] Sanofi, Bridgewater, MA USA
[6] Regeneron Pharmaceut Inc, Tarrytown, NY USA
来源：
ALLERGY | 2018年 / 73卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
0854
引用
收藏
页码：464 / 465
页数：2
相关论文
共 50 条
  • [41] Dupilumab reduces systemic corticosteroid use in children with uncontrolled moderate-to-severe asthma regardless of prior exacerbation history
    Ducharme, Francine M.
    Sher, Lawrence D.
    Hamelmann, Eckard
    de Mir, Ines
    Xia, Changming
    Gall, Rebecca
    Ledanois, Olivier
    Jacob-Nara, Juby A.
    Sacks, Harry
    Rowe, Paul J.
    Deniz, Yamo
    RESPIROLOGY, 2023, 28 : 342 - 342
  • [42] Dupilumab improves lung function and reduces severe exacerbations in uncontrolled persistent asthma patients with high and low reversibility
    Castro, Mario
    Maspero, Jorge F.
    Staudinger, Heribert
    Jayawardena, Shyamalie
    Maroni, Jaman
    Rowe, Paul
    Amin, Nikhil
    Pirozzi, Gianluca
    Graham, Neil M. H.
    Teper, Ariel
    EUROPEAN RESPIRATORY JOURNAL, 2017, 50
  • [43] Dupilumab Produces Rapid and Sustained Improvements in Asthma-Related Symptoms in Patients with Uncontrolled, Moderate-To-Severe Asthma from the LIBERTY ASTHMA QUEST Study
    Corren, J.
    Castro, M.
    Guillonneau, S.
    Chao, J.
    Amin, N.
    Pirozzi, G.
    Graham, N. M.
    Teper, A.
    Khan, A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [44] Dupilumab improves lung function and reduces severe exacerbations in uncontrolled persistent asthma patients with ongoing allergic rhinitis
    Weinstein, Steven
    Staudinger, Heribert
    Guillonneau, Sophie
    Taniou, Christine
    Eckert, Laurent
    Joish, Vijay
    Maroni, Jaman
    Rowe, Paul
    Amin, Nikhil
    Pirozzi, Gianluca
    Graham, Neil
    Teper, Ariel
    EUROPEAN RESPIRATORY JOURNAL, 2017, 50
  • [45] Dupilumab improves lung function and reduces severe exacerbations in patients with uncontrolled persistent asthma with and without history of atopy
    Maspero, J.
    Gawchik, S. M.
    Zhang, B.
    Pirozzi, G.
    Staudinger, H.
    Evans, R. R.
    Graham, N. M. H.
    Louis-Tisserand, M.
    Teper, A.
    ALLERGY, 2016, 71 : 530 - 530
  • [46] Impact of severe exacerbations on lung function in dupilumab-treated patients: LIBERTY ASTHMA QUEST
    Papi, Alberto
    Chapman, Kenneth R.
    Castro, Mario
    Jackson, Daniel J.
    Daizadeh, Nadia
    Pandit-Abid, Nami
    Deniz, Yamo
    Rowe, Paul
    Ortiz, Benjamin
    EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [47] Dupilumab Effect on Lung Function in Patients with Uncontrolled, Moderate-to-Severe Asthma with an Allergic Phenotype
    Castro, M.
    Corren, J.
    Casale, T. B.
    Quirce, S.
    Rice, M. S.
    Deniz, Y.
    Rowe, P.
    Amin, N.
    Teper, A.
    PNEUMOLOGIE, 2020, 74 : S89 - S89
  • [48] Dupilumab Effect on Lung Function in Patients With Uncontrolled, Moderate-to-Severe Asthma With an Allergic Phenotype
    Castro, Mario
    Corren, Jonathan
    Casale, Thomas B.
    Quirce, Santiago
    Rice, Megan S.
    Deniz, Yamo
    Rowe, Paul
    Amin, Nikhil
    Teper, Ariel
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [49] EFFICACY OF DUPILUMAB IN PATIENTS WITH UNCONTROLLED, MODERATE-TO-SEVERE ASTHMA AND WITH HIGH SLEEP DISTURBANCE: A POST HOC ANALYSIS FROM LIBERTY ASTHMA QUEST
    Maspero, J.
    Shafazand, S.
    Cole, J.
    Pavord, I. D.
    Busse, W. W.
    Msihid, J.
    Gall, R.
    Soler, X.
    Siddiqui, S.
    Khan, A. H.
    Gomez, L. D. P.
    Jacob-Nara, J. A.
    VALUE IN HEALTH, 2022, 25 (07) : S550 - S550
  • [50] Dupilumab reduced impact of severe exacerbations on lung function in patients with moderate-to-severe type 2 asthma
    Papi, Alberto
    Corren, Jonathan
    Castro, Mario
    Domingo, Christian
    Rogers, Linda
    Chapman, Kenneth R.
    Jackson, Daniel J.
    Daizadeh, Nadia
    Pandit-Abid, Nami
    Gall, Rebecca
    Jacob-Nara, Juby A.
    Rowe, Paul J.
    Deniz, Yamo
    Ortiz, Benjamin
    ALLERGY, 2023, 78 (01) : 233 - 243
12345